以下部分引用 AI 总结，现阶段 AI 仍然有幻觉。请以内容的原文为准。
数据新鲜度群聊 07-14 ✓卖方 07-14 ✓Wrap 断档15天 ✕News 07-15 ✓X 断档12天 ✕页面生成 07-15
NOVO NORDISK
9 atoms · 跨 6 天 · 首见 2026-05-01 · 最近 2026-07-01
三色: 🟦 fact 8 · 🟥 take 1 · stance ▲5/▼1/◆0
来源: X 9
时态: fresh:8 · stale:1
标签: 好信源:8 · 好数字:5
立场 (position) (1)
展开 1 条老旧 / 已过期
- 2026-05-11
[老旧] · 目标价
CITIGROUP RAISES NOVO NORDISK TARGET PRICE TO DKK 290 FROM DKK 275
tags: 好信源 · → daily
value: qty=290 · currency=DKK · previous=275
事实 (fact) (8)
- 2026-07-01 ⭐ · WEGOVY Medicare 月度共付额
WEGOVY NOW AVAILABLE TO ELIGIBLE MEDICARE PATIENTS FOR $50 MONTHLY COPAY
tags: 好数字·好信源 · → daily
value: qty=$50
- 2026-07-01 ⭐ · WEGOVY Medicare Bridge 项目截止日期
NOVO NORDISK MEDICARE GLP-1 BRIDGE PROGRAM FOR WEGOVY RUNS THROUGH END OF 2027
tags: 好数字·好信源 · → daily
value: date=2027-12-31
- 2026-05-12 ⭐ · 高剂量WEGOVY帮助患者减重比例
NOVO NORDISK SAYS HIGH-DOSE WEGOVY HELPED SOME PATIENTS LOSE NEARLY 28% OF THEIR WEIGHT - CNBC
tags: 好数字·好信源 · → daily
value: qty=28% · direction=nearly
- 2026-05-01 ⭐ · OZEMPIC PILLS 获批用于 2 型糖尿病心血管风险降低
NOVO NORDISK GOT APPROVAL FOR OZEMPIC PILLS, THE FIRST ORAL GLP-1 FOR REDUCING CARDIOVASCULAR RISKS IN TYPE 2 DIABETES.
tags: 好数字·好信源 · → daily
value: qty=首个口服 GLP-1 · date=2026-05-01
- 2026-07-01 · WEGOVY Medicare 可及性
WEGOVY® IS NOW ACCESSIBLE TO ELIGIBLE MEDICARE BENEFICIARIES LIVING WITH OBESITY THROUGH MEDICARE GLP-1 BRIDGE
tags: 好信源 · → daily
- 2026-06-11 · WEGOVY8 pills approval status
NOVO NORDISK'S WEGOVY8 PILLS (SEMAGLUTIDE TABLETS) ARE NOW THE FIRST DAILY GLP-1 WEIGHT LOSS OPTION.
tags: 好信源 · → daily
- 2026-06-16 · 计划在中国提交口服Wegovy申请
$NVO's CEO told Reuters the company plans to seek Chinese regulatory approval for its Wegovy weight-loss pill “very soon,” likely within a few months.
tags: 好信源 · → daily
value: direction=submission
- 2026-06-16 · 面临司美格鲁肽专利到期和仿制药竞争
Novo also faces pressure from semaglutide patent expiry in China and expected generic competition starting next year.
tags: 好数字 · → daily
value: date=2026
时间轴 (近 20)
- 2026-07-01 ·
fact · WEGOVY Medicare 可及性 · → daily
- 2026-07-01 ·
fact · WEGOVY Medicare 月度共付额 · → daily
- 2026-07-01 ·
fact · WEGOVY Medicare Bridge 项目截止日期 · → daily
- 2026-06-16 ·
fact · 计划在中国提交口服Wegovy申请 · → daily
- 2026-06-16 ·
fact · 面临司美格鲁肽专利到期和仿制药竞争 · → daily
- 2026-06-11 ·
fact · WEGOVY8 pills approval status · → daily
- 2026-05-12 ·
fact · 高剂量WEGOVY帮助患者减重比例 · → daily
- 2026-05-11 ·
position · 目标价 · → daily
- 2026-05-01 ·
fact · OZEMPIC PILLS 获批用于 2 型糖尿病心血管风险降低 · → daily
← 实体目录 · 系统日志